Lhermitte's sign following chemotherapy with docetaxel.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 9484402.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Specific causes for Lhermitte's sign (LS) in cancer patients are spinal cord compression, radiation therapy to the spinal cord, and cisplatin chemotherapy. We observed a transient LS in five of 87 patients treated with more than two cycles of 100 mg/m2 docetaxel (Taxotere). LS developed either concurrently or after the onset of docetaxel-induced sensory neuropathy, and disappeared after the discontinuation or dose reduction of chemotherapy.
Medical subject headings
- Antineoplastic Agents, Phytogenic
- Neoplasms
- Paclitaxel
- Spinal Cord Diseases
- Taxoids